fig2

Figure 2. Strategic Roadmap for Prevention and Control of MASLD and ALD. Associations and international guidelines should acknowledge the definition of MASLD and recommend screening for patients with CMRFs. This screening should also integrate related conditions such as HIV, viral hepatitis, and other NCDs. Giving priority to active screening for ALD/AUD and MASLD is crucial, and advocating for their inclusion in the ICD is necessary. These efforts will hopefully generate political support, facilitate policy prioritization, and secure funding for prevention, control, and treatment trials. MASLD: Metabolic-associated steatotic liver disease; ALD: alcohol-associated liver disease; CMRFs: cardiometabolic risk factors; HIV: human immunodeficiency virus; NCDS: non-communicable diseases; AUD: alcohol use disorder; ICD: International Classification of Diseases.